Log In
Print
BCIQ
Print
Print this Print this
 

MORAb-004

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionHumanized IgG mAb against CD248 endosialin (TEM1)
Molecular Target CD248 endosialin (TEM1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today